Very low dose steroid for new rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy clinical trials.
This study tests whether a very low dose of the steroid prednisolone can safely help people with newly diagnosed rheumatoid arthritis who haven't yet started other treatments. It aims to control symptoms early without the side effects of higher doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been newly diagnosed with rheumatoid arthritis by a doctor.
- You should not have taken any disease-modifying medications for RA before.
- You cannot be pregnant or planning to become pregnant.
- You must not have used steroid medications in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways of slowly lowering your steroid dose (prednisolone) to see which is safer and works better for people with stable rheumatoid arthritis. You may join if you have been on a low, steady dose of steroids and your arthritis is well controlled.
This study compares two different schedules for reducing prednisone (a steroid) in people with rheumatoid arthritis who are also taking another standard arthritis medicine. The goal is to find the safest and most effective way to taper off steroids without causing a flare-up.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
This trial tests whether spironolactone can reduce symptoms and inflammation in people with rheumatoid arthritis that is still active despite standard arthritis medicines. You may be able to join if your rheumatoid arthritis remains active and your current treatment plan has been stable for at least several months.
This trial aims to find out if a simple blood test (biomarker) can show whether a lower dose of rituximab will work for people with rheumatoid arthritis. If successful, it could help patients maintain good results with less medicine and fewer side effects.
Hear when a new Rhematoid Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.